10 results
People

Minor use permit for erythromycin in finfish

Project number: 2021-027
Project Status:
Current
Budget expenditure: $95,000.00
Principal Investigator: Marty R. Deveney
Organisation: University of Adelaide
Project start/end date: 21 Oct 2021 - 30 Jul 2022
Contact:
FRDC

Need

There are no antimicrobials permitted or registered for use in finfish in Australia effective against gram positive bacteria (e.g. Streptococcus and Lactococcus). In finfish aquaculture, erythromycin (ERYC) is the best antimicrobial against gram positive organisms. The aquaculture industry and the Subcommittee for Aquatic Animal Health identified access to this product for finfinfish as a priority. Bacterial diseases are increasingly managed by eradication, maintenance of animals of specified health status, vaccination, and good hygiene, but antimicrobial therapy remains vital for treating bacterial diseases in finfish aquaculture. Appropriate use of antimicrobials can alleviate illness and suffering, improve welfare, increase speed of recovery, reduce spread of infection. Use of ERYC is not intended for prophylactic treatment, but as a tool for veterinarians to manage disease outbreaks. Use in South Australia, for example, is sporadic (~1 to 2 times per 3-5 years for a sector). The Aquaculture industry is committed to Australia's antimicrobial strategy, and as required by APVMA this proposal includes an antimicrobial resistance risk assessment. Available data for ERYC can satisfy the APVMA module requirements for efficacy, chemistry and manufacture, toxicology, trade and occupational health and safety. These are available in published literature, a range of industry studies of animals treated off-label and laboratory studies. There is a lack of data to satisfy the requirements mainly in the environment modules and the antimicrobial resistance risk assessment.

ERYC was ranked low by the Expert Advisory Group on Antimicrobial Assessment (EAGAR) as an antimicrobial for which there are a reasonable number of alternative agents in different classes available to treat most infections. Although it is listed on the WHO list of essential medicines, it is registered for use in cattle, pigs and sheep (APVMA #84160) and poultry (APVMA #50742) in Australia and the WHO list can be modified locally to suit the availability and sophistication of the animal and human health systems in WHO member countries. The APVMA PAA assessed ERYC as suitable for assessment for use in finfish.

Objectives

1. Obtain data to satisfy identified gaps and collate available data to satisfy requirements of minor use permit application.
2. Collate and submit minor use permit application.
Industry
PROJECT NUMBER • 2018-097
PROJECT STATUS:
COMPLETED

Survey of Enterprise-level Biosecurity across the Australian Aquaculture Industry

The Australian Government Department of Agriculture and Water Resources (the department) commissioned the independent research company Instinct and Reason to conduct a survey aimed at farm owners/managers in the Australian aquaculture industry. The survey aimed to investigate the level of...
ORGANISATION:
Instinct and Reason
Communities
PROJECT NUMBER • 2018-075
PROJECT STATUS:
COMPLETED

Aquaculture-Community Futures: North West Tasmania

This report discusses a study conducted by the Institute for Marine and Antarctic Studies at the University of Tasmania on marine and costal wellbeing and how it can be considered in regional marine and coastal development decision making. The need for this project arose from a desire by selected...
ORGANISATION:
University of Tasmania (UTAS)